Revenue

Terveystalo's revenue has experienced a decline in the last quarter, with a 21.8% decrease in the Portfolio Businesses segment and a 1.8% decrease in the Sweden segment. This downturn can be attributed to the expiration of contracts and weak demand in the outsourcing services and staffing services categories. Furthermore, the company's revenue from dental care has shown a modest increase, indicating some resilience in this area. Looking ahead, Terveystalo's guidance suggests that revenue growth will be sluggish in the second half of the year, with the demand environment expected to gradually improve but not fully materialize within the current year. Overall, Terveystalo's revenue performance in the last quarter reflects a challenging market environment and the company's need to adapt to changing customer needs and preferences.

The realised revenue for Q2 2026 is 293.3 million Euros, while the predicted revenue for Q2 2027 (e) is 279.2 million Euros. The revenue is expected to decrease by 14.1 million Euros, which translates to a 4.8% decrease from the realised value. The revenue is expected to decrease by 84.1 million Euros from 2025 to 2026, which is a 6.6% change. From 2026 to 2027, the revenue is expected to decrease by 50.7 million Euros, which is a 4.3% change. The annual revenue values are 1278.8 million Euros in 2025, 1184.7 million Euros in 2026, and 1134.0 million Euros in 2027.

Ebit

Terveystalo's EBIT profitability has been experiencing a decline, with a notable drop in the first half of 2026 compared to the same period in 2025. This decrease can be attributed to a challenging demand environment, which has impacted the company's ability to maintain its historical profitability levels. Furthermore, the prevalence of upper respiratory infections has been lower than expected, contributing to the decline in profitability. Despite this, Terveystalo's management remains optimistic about the company's prospects, citing a gradually improving demand environment and the expectation that profitability will recover in the second half of 2026. However, the company's ability to achieve its medium-term financial targets, including a leverage ratio of no more than 3x, will depend on its ability to navigate these near-term challenges and capitalize on future growth opportunities.

The realised Ebit for Q2 2026 is 23.2 million Euros, while the predicted Ebit for Q2 2027 (e) is 33.6 million Euros. The expected change in Ebit from Q2 2026 to Q2 2027 (e) is 10.4 million Euros, which represents a 44.8% increase. The expected change in Ebit from 2025 to 2026 is a decrease of 33.9 million Euros, which translates to a 24.5% decrease. From 2026 to 2027, the expected change is an increase of 9.5 million Euros, representing a 9.1% increase. The annual Ebit values are 137.5 million Euros in 2025, 104.6 million Euros in 2026, and 114.1 million Euros in 2027.

Profit befor tax

The realised profit before tax in Q2 2026 is 17.2 million Euros, and the predicted profit before tax in Q2 2027 (e) is 33.6 million Euros. The expected change in profit before tax from Q2 2026 to Q2 2027 (e) is 16.4 million Euros, which represents a 95.3% increase. The profit before tax is expected to decrease by 23.3 million Euros from 2025 to 2026, which is a 20% change. From 2026 to 2027, the profit before tax is expected to increase by 20.3 million Euros, which is a 22% change. The annual values for profit before tax are 116.1 million Euros in 2025, 93.8 million Euros in 2026, and 114.1 million Euros in 2027.

Profit

The realised profit for Q2 2026 is 13.8 million Euros, while the predicted profit for Q2 2027 (e) is 26.9 million Euros. The expected change in profit from Q2 2026 to Q2 2027 (e) is 13.1 million Euros, representing a 94.9% increase. The profit is expected to decrease by 18.8 million Euros from 2025 to 2026, which is a 20.3% decrease. From 2026 to 2027, the profit is expected to increase by 17.5 million Euros, which is a 23.6% increase. The annual profit values are 92.6 million Euros in 2025, 74.8 million Euros in 2026, and 91.3 million Euros in 2027.